ATHE Stock Summary and Trading Ideas (Alterity Therapeutics Limited - American Depositary Shares | NASDAQ:ATHE)

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.

Alterity Therapeutics Limited - American Depositary Shares trades on the NASDAQ stock market under the symbol ATHE.

As of March 13, 2025, ATHE stock price declined to $3.79 with 21,098 million shares trading.

ATHE has a beta of 2.15, meaning it tends to be more sensitive to market movements. ATHE has a correlation of 0.05 to the broad based SPY ETF.

ATHE has a market cap of $40.50 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, ATHE traded as high as $8.73 and as low as $1.00.

ATHE has outperformed the market in the last year with a return of +128.3%, while the SPY ETF gained +8.7%. In the last 3 month period, ATHE beat the market returning +70.7%, while SPY returned -7.9%. However, in the most recent 2 weeks ATHE has underperformed the stock market by returning -8.5%, while SPY returned -6.7%.

ATHE support price is $3.64 and resistance is $4.03 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ATHE shares will trade within this expected range on the day.